Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Vaccines

Free Subscription 19.07.2021 1 AIDS 1 Ann Intern Med 1 Ann N Y Acad Sci 10 BMJ 5 Clin Infect Dis 1 J Gen Virol 1 J Immunol 2 JAMA 1 Lancet 3 MMWR Morb Mortal Wkly Rep 11 N Engl J Med 2 Nat Immunol 4 Nat Med 4 Pediatr Infect Dis J 7 PLoS One 2 Science 11 Vaccine

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AIDS

1. RUDDY JA, Boyarsky BJ, Bailey JR, Karaba AH, et al
   Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in persons with HIV.
   AIDS. 2021 Jul 8. pii: 00002030-900000000-96349.
   PubMed         Abstract available
   
   

   
   Ann Intern Med

2. KLOMPAS M, Pearson M, Morris C
   The Case for Mandating COVID-19 Vaccines for Health Care Workers.
   Ann Intern Med. 2021 Jul 13. doi: 10.7326/M21-2366.
   PubMed        
   
   

   
   Ann N Y Acad Sci

3. SUMMAN A, Nandi A, Deo S, Laxminarayan R, et al
   Improving vaccination coverage and timeliness through periodic intensification of routine immunization: evidence from Mission Indradhanush.
   Ann N Y Acad Sci. 2021 Jul 15. doi: 10.1111/nyas.14657.
   PubMed         Abstract available
   
   

   
   BMJ

4. CROZIER A, Dunning J, Rajan S, Semple MG, et al
   Could expanding the covid-19 case definition improve the UK's pandemic response?
   BMJ. 2021;374:n1625.
   PubMed        
   
   
5. TANNE JH
   Covid-19: Biden renews vaccines push as cases and deaths rise among unvaccinated people.
   BMJ. 2021;374:n1742.
   PubMed        
   
   
6. WILKINSON D, Finlay I, Pollard AJ, Forsberg L, et al
   Should we delay covid-19 vaccination in children?
   BMJ. 2021;374:n1687.
   PubMed        
   
   
7. TORJESEN I
   Covid-19: Free rapid testing may end once most adults are fully vaccinated.
   BMJ. 2021;374:n1760.
   PubMed        
   
   
8. DYER O
   Covid-19: Turkmenistan becomes first country to make vaccination mandatory for all adults.
   BMJ. 2021;374:n1766.
   PubMed        
   
   
9. TINARI S, Riva C
   Donuts, drugs, booze, and guns: what governments are offering people to take covid-19 vaccines.
   BMJ. 2021;374:n1737.
   PubMed        
   
   
10. DYER O
    Covid-19: Regulators warn that rare Guillain-Barre cases may link to J&J and AstraZeneca vaccines.
    BMJ. 2021;374:n1786.
    PubMed        
    
    
11. WISE J
    Covid-19: France and Greece make vaccination mandatory for healthcare workers.
    BMJ. 2021;374:n1797.
    PubMed        
    
    
12. O'DOWD A
    Covid-19 vaccination: GPs ruled out of booster campaign at practice level.
    BMJ. 2021;374:n1811.
    PubMed        
    
    
13. TORJESEN I
    Covid-19: Vaccine centres operating at 30% capacity as young people stay away.
    BMJ. 2021;374:n1808.
    PubMed        
    
    

    
    Clin Infect Dis

14. SKOWRONSKI DM, Setayeshgar S, Zou M, Prystajecky N, et al
    Single-dose mRNA vaccine effectiveness against SARS-CoV-2, including Alpha and Gamma variants: a test-negative design in adults 70 years and older in British Columbia, Canada.
    Clin Infect Dis. 2021 Jul 9. pii: 6318435. doi: 10.1093.
    PubMed         Abstract available
    
    
15. DAWOOD FS, Naleway AL, Flannery B, Levine MZ, et al
    Comparison of the Immunogenicity of Cell Culture-Based and Recombinant Quadrivalent Influenza Vaccines to Conventional Egg-Based Quadrivalent Influenza Vaccines among Healthcare Personnel Aged 18-64 Years: A Randomized Open-Label Trial.
    Clin Infect Dis. 2021 Jul 10. pii: 6318730. doi: 10.1093.
    PubMed         Abstract available
    
    
16. IJAZ S, Derrick J, Shute J, Ireland G, et al
    Mother To Infant Transmission Of Hepatitis B Virus In The Face Of Neonatal Immunisation Is Not Necessarily Primary Vaccine Failure.
    Clin Infect Dis. 2021 Jul 12. pii: 6319332. doi: 10.1093.
    PubMed         Abstract available
    
    
17. LIN DY, Gu Y, Zeng D, Janes HE, et al
    Evaluating Vaccine Efficacy Against SARS-CoV-2 Infection.
    Clin Infect Dis. 2021 Jul 14. pii: 6321290. doi: 10.1093.
    PubMed         Abstract available
    
    
18. TOTA JE, Giuliano AR, Goldstone SE, Dubin B, et al
    Anogenital HPV Infection, Seroprevalence, and Risk Factors for HPV Seropositivity Among Sexually Active Men Enrolled in a Global HPV Vaccine Trial.
    Clin Infect Dis. 2021 Jul 15. pii: 6321740. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Gen Virol

19. RESLAN L, Mishra N, Finianos M, Zakka K, et al
    The origins of G12P[6] rotavirus strains detected in Lebanon.
    J Gen Virol. 2021;102.
    PubMed         Abstract available
    
    

    
    J Immunol

20. BARBER-AXTHELM IM, Kelly HG, Esterbauer R, Wragg KM, et al
    Coformulation with Tattoo Ink for Immunological Assessment of Vaccine Immunogenicity in the Draining Lymph Node.
    J Immunol. 2021 Jul 9. pii: jimmunol.2001299. doi: 10.4049/jimmunol.2001299.
    PubMed         Abstract available
    
    

    
    JAMA

21. ABBASI J
    Study Suggests Lasting Immunity After COVID-19, With a Big Boost From Vaccination.
    JAMA. 2021 Jul 14. pii: 2782139. doi: 10.1001/jama.2021.11717.
    PubMed        
    
    
22. GOLDSHTEIN I, Nevo D, Steinberg DM, Rotem RS, et al
    Association Between BNT162b2 Vaccination and Incidence of SARS-CoV-2 Infection in Pregnant Women.
    JAMA. 2021 Jul 12. pii: 2782047. doi: 10.1001/jama.2021.11035.
    PubMed         Abstract available
    
    

    
    Lancet

23. TANRIOVER MD, Doganay HL, Akova M, Guner HR, et al
    Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey.
    Lancet. 2021 Jul 8. pii: S0140-6736(21)01429.
    PubMed         Abstract available
    
    

    
    MMWR Morb Mortal Wkly Rep

24. SCHERER AM, Gedlinske AM, Parker AM, Gidengil CA, et al
    Acceptability of Adolescent COVID-19 Vaccination Among Adolescents and Parents of Adolescents - United States, April 15-23, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:997-1003.
    PubMed         Abstract available
    
    
25. WONG CA, Dowler S, Moore AF, Sosne EF, et al
    COVID-19 Vaccine Administration, by Race and Ethnicity - North Carolina, December 14, 2020-April 6, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:991-996.
    PubMed         Abstract available
    
    
26. PINGALI C, Meghani M, Razzaghi H, Lamias MJ, et al
    COVID-19 Vaccination Coverage Among Insured Persons Aged >/=16 Years, by Race/Ethnicity and Other Selected Characteristics - Eight Integrated Health Care Organizations, United States, December 14, 2020-May 15, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:985-990.
    PubMed         Abstract available
    
    

    
    N Engl J Med

27. WANG GL, Wang ZY, Duan LJ, Meng QC, et al
    Susceptibility of Circulating SARS-CoV-2 Variants to Neutralization.
    N Engl J Med. 2021 Apr 6. doi: 10.1056/NEJMc2103022.
    PubMed        
    
    
28. SHEN X, Tang H, Pajon R, Smith G, et al
    Neutralization of SARS-CoV-2 Variants B.1.429 and B.1.351.
    N Engl J Med. 2021 Apr 7. doi: 10.1056/NEJMc2103740.
    PubMed        
    
    
29. ANICHINI G, Terrosi C, Gandolfo C, Gori Savellini G, et al
    SARS-CoV-2 Antibody Response in Persons with Past Natural Infection.
    N Engl J Med. 2021 Apr 14. doi: 10.1056/NEJMc2103825.
    PubMed        
    
    
30. LAI KY, Au SY, Fong KM
    Thrombotic Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.
    N Engl J Med. 2021;385:e11.
    PubMed        
    
    
31. CHOI PY
    Thrombotic Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.
    N Engl J Med. 2021;385:e11.
    PubMed        
    
    
32. EICHINGER S, Warkentin TE, Greinacher A
    Thrombotic Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination. Reply.
    N Engl J Med. 2021;385:e11.
    PubMed        
    
    
33. ROPPER AH, Klein JP
    Cerebral Venous Thrombosis.
    N Engl J Med. 2021;385:59-64.
    PubMed        
    
    
34. BAROUCH DH, Stephenson KE, Sadoff J, Yu J, et al
    Durable Humoral and Cellular Immune Responses 8 Months after Ad26.COV2.S Vaccination.
    N Engl J Med. 2021 Jul 14. doi: 10.1056/NEJMc2108829.
    PubMed        
    
    
35. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Monoclonal Antibodies and Vaccine Boosts.
    N Engl J Med. 2021;385:e18.
    PubMed        
    
    
36. NORMARK J, Vikstrom L, Gwon YD, Persson IL, et al
    Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination.
    N Engl J Med. 2021 Jul 14. doi: 10.1056/NEJMc2110716.
    PubMed        
    
    
37. MOON S, Alonso Ruiz A, Vieira M
    Averting Future Vaccine Injustice.
    N Engl J Med. 2021;385:193-196.
    PubMed        
    
    

    
    Nat Immunol

38. CUPOVIC J, Ring SS, Onder L, Colston JM, et al
    Adenovirus vector vaccination reprograms pulmonary fibroblastic niches to support protective inflating memory CD8(+) T cells.
    Nat Immunol. 2021 Jul 15. pii: 10.1038/s41590-021-00969.
    PubMed         Abstract available
    
    
39. DAI L, Xu K, Li J, Huang Q, et al
    Protective Zika vaccines engineered to eliminate enhancement of dengue infection via immunodominance switch.
    Nat Immunol. 2021 Jul 15. pii: 10.1038/s41590-021-00966.
    PubMed         Abstract available
    
    

    
    Nat Med

40. CHEMAITELLY H, Yassine HM, Benslimane FM, Al Khatib HA, et al
    mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar.
    Nat Med. 2021 Jul 9. pii: 10.1038/s41591-021-01446.
    PubMed         Abstract available
    
    
41. LOUBET P, Wittkop L, Tartour E, Parfait B, et al
    A French cohort for assessing COVID-19 vaccine responses in specific populations.
    Nat Med. 2021 Jul 12. pii: 10.1038/s41591-021-01435.
    PubMed        
    
    
42. BARROS-MARTINS J, Hammerschmidt SI, Cossmann A, Odak I, et al
    Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination.
    Nat Med. 2021 Jul 14. pii: 10.1038/s41591-021-01449.
    PubMed         Abstract available
    
    
43. O'LEARY K
    Another COVID-19 vaccine to boost rollout.
    Nat Med. 2021 Jul 15. pii: 10.1038/d41591-021-00045.
    PubMed        
    
    

    
    Pediatr Infect Dis J

44. BLUMENFELD O, Lawrence G, Shulman LM, Laron Z, et al
    Use of the Whole Country Insulin Consumption Data in Israel to Determine the Prevalence of Type 1 Diabetes in Children <5 Years of Age Before and During Rotavirus Vaccination.
    Pediatr Infect Dis J. 2021;40:771-773.
    PubMed         Abstract available
    
    
45. HASSAN J, Toh TH, Sivapunniam SK, Hasim R, et al
    Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Quadrivalent Human Papillomavirus Vaccine in Boys and Girls 9-13 Years of Age in Malaysia: A Phase IIIb, Randomized, Open-label Study.
    Pediatr Infect Dis J. 2021;40:774-781.
    PubMed         Abstract available
    
    
46. WIERINGA JW, van Beek RHT, Rovekamp LW, Driessen GJA, et al
    Response to Vaccination in Infants Exposed to Antitumor Necrosis Factor Alpha In Utero.
    Pediatr Infect Dis J. 2021 Jul 13. pii: 00006454-900000000-95765.
    PubMed         Abstract available
    
    
47. SARMIENTO CLEMENTE A, Amerson-Brown MH, Foster CE
    An Adolescent With Neurobrucellosis Caused by Brucella abortus Cattle Vaccine Strain RB51.
    Pediatr Infect Dis J. 2021 Jul 13. pii: 00006454-900000000-95761.
    PubMed         Abstract available
    
    

    
    PLoS One

48. KOLLI SK, Salman AM, Ramesar J, Chevalley-Maurel S, et al
    Screening of viral-vectored P. falciparum pre-erythrocytic candidate vaccine antigens using chimeric rodent parasites.
    PLoS One. 2021;16:e0254498.
    PubMed         Abstract available
    
    
49. INOUE K, Kashima S
    Association of the past epidemic of Mycobacterium tuberculosis with mortality and incidence of COVID-19.
    PLoS One. 2021;16:e0253169.
    PubMed         Abstract available
    
    
50. YASSI A, Grant JM, Lockhart K, Barker S, et al
    Infection control, occupational and public health measures including mRNA-based vaccination against SARS-CoV-2 infections to protect healthcare workers from variants of concern: A 14-month observational study using surveillance data.
    PLoS One. 2021;16:e0254920.
    PubMed         Abstract available
    
    
51. STODDARD M, Sarkar S, Yuan L, Nolan RP, et al
    Beyond the new normal: Assessing the feasibility of vaccine-based suppression of SARS-CoV-2.
    PLoS One. 2021;16:e0254734.
    PubMed         Abstract available
    
    
52. LU M, Ishwaran H
    Cure and death play a role in understanding dynamics for COVID-19: Data-driven competing risk compartmental models, with and without vaccination.
    PLoS One. 2021;16:e0254397.
    PubMed         Abstract available
    
    
53. ALAGOZ O, Sethi AK, Patterson BW, Churpek M, et al
    The impact of vaccination to control COVID-19 burden in the United States: A simulation modeling approach.
    PLoS One. 2021;16:e0254456.
    PubMed         Abstract available
    
    
54. AHMED MH, Kanfe SG, Jarso MH
    Intention to receive vaccine against COVID-19 and associated factors among health professionals working at public hospitals in resource limited settings.
    PLoS One. 2021;16:e0254391.
    PubMed         Abstract available
    
    

    
    Science

55. COHEN J
    Can immune responses predict which vaccines work best?
    Science. 2021;373:142-143.
    PubMed        
    
    
56. WADMAN M
    Journal retracts paper claiming COVID-19 vaccines kill.
    Science. 2021;373:147.
    PubMed        
    
    

    
    Vaccine

57. AT THOBARI J, Damayanti W, Haposan JH, Nirwati H, et al
    Safety and immunogenicity of human neonatal RV3 rotavirus vaccine (Bio Farma) in adults, children, and neonates in Indonesia: Phase I Trial.
    Vaccine. 2021 Jul 6. pii: S0264-410X(21)00832.
    PubMed         Abstract available
    
    
58. DING Y, Luo L, Luo Y, Zhao D, et al
    A novel combined vaccine against classical swine fever and porcine epidemic diarrhea viruses elicits a significant Th2-favored humoral response in mice.
    Vaccine. 2021 Jul 7. pii: S0264-410X(21)00846.
    PubMed         Abstract available
    
    
59. CLARKE M, Goodchild LM, Evans S, Giles LC, et al
    Body mass index and vaccine responses following influenza vaccination during pregnancy.
    Vaccine. 2021 Jul 12. pii: S0264-410X(21)00826.
    PubMed         Abstract available
    
    
60. GOMEZ M, McCollum J, Wang H, Bachchhav S, et al
    Evaluation of the stability of a spray-dried tuberculosis vaccine candidate designed for dry powder respiratory delivery.
    Vaccine. 2021 Jul 10. pii: S0264-410X(21)00861.
    PubMed         Abstract available
    
    
61. GOOCH KE, Smith TRF, Salguero FJ, Fotheringham SA, et al
    One or two dose regimen of the SARS-CoV-2 synthetic DNA vaccine INO-4800 protects against respiratory tract disease burden in nonhuman primate challenge model.
    Vaccine. 2021 Jun 23. pii: S0264-410X(21)00807.
    PubMed         Abstract available
    
    
62. GUKTUR RE, Nep EI, Asala O, Olorunfemi PO, et al
    Carboxymethylated and acetylated xerogel derivatives of Plectranthus esculentus starch protect Newcastle disease vaccines against cold chain failure.
    Vaccine. 2021 Jul 9. pii: S0264-410X(21)00812.
    PubMed         Abstract available
    
    
63. ZHANG T, Zhang J, Shao X, Feng S, et al
    Effectiveness of 13-valent pneumococcal conjugate vaccine against community acquired pneumonia among children in China, an observational cohort study.
    Vaccine. 2021 Jul 9. pii: S0264-410X(21)00836.
    PubMed         Abstract available
    
    
64. FONGWEN N, Delrieu I, Ham LH, Gubler DJ, et al
    Implementation strategies for the first licensed dengue vaccine: A meeting report.
    Vaccine. 2021 Jul 9. pii: S0264-410X(21)00845.
    PubMed         Abstract available
    
    
65. TERNA RICHARD M, Taiwo L, Jean Baptiste AE, Bawa S, et al
    Planning for supplemental immunization activities using the readiness assessment dashboard: Experience from 2017/2018 Measles vaccination campaign, Nigeria.
    Vaccine. 2021 Jul 8. pii: S0264-410X(21)00831.
    PubMed         Abstract available
    
    
66. HINES AM, Murphy N, Mullin C, Barillas J, et al
    Henoch-Schonlein purpura presenting post COVID-19 vaccination.
    Vaccine. 2021 Jun 30. pii: S0264-410X(21)00841.
    PubMed        
    
    
67. MATEO-URDIALES A, Del Manso M, Andrianou X, Spuri M, et al
    Initial impact of SARS-Cov-2 vaccination on healthcare workers in Italy- Update on the 28th of March 2021.
    Vaccine. 2021 Jul 7. pii: S0264-410X(21)00862.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: